Recovery Centers of America’s Chief Medical Officer Jason Kirby, DO, MBA, DFASAM, recently authored an article featured in Drug Discovery Online.
Jason explores the growing research around GLP-1 medications and their potential role in addiction treatment, including how these medications may impact cravings, dopamine signaling, reward pathways, relapse prevention, and the connection between metabolic health and substance use disorders. He also discusses the limitations of current research, the importance of evidence-based addiction care, and what the future of GLP-1 therapies could mean for patients seeking recovery from alcohol and drug addiction.
RCA’s personalized, evidence-based care combined with the compassion and understanding of our staff has helped nearly 100,000 patients achieve lasting recovery. If you or a loved one is struggling with addiction or mental health, our team is here to help. Call 1.800.RECOVERY or contact us online today.
